Eijiro Nagasaki

Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015  Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis

Kenjiro Aogi, Hideki Takeuchi, Toshiaki Saeki et al. · International Journal of Clinical Oncology · 2020 · 107 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansine

Shin Kan, Shigeo Koido, Masato Okamoto et al. · Oncology Reports · 2015 · 61 citations · Full text

Medicine, Oncology, Pharmacology +17

Gemcitabine enhances Wilms’ tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response

Akitaka Takahara, Shigeo Koido, Masaki Ito et al. · Cancer Immunology Immunotherapy · 2011 · 59 citations · Full text

Medicine, Oncology, Pharmacology +14

Combination chemotherapy (cyclophosphamide, doxorubicin, and vincristine with continuous‐infusion cisplatin and etoposide) and radiotherapy with stem cell support can be beneficial for adolescents and adults with estheisoneuroblastoma

Yuko Mishima, Eijiro Nagasaki, Yasuhito Terui et al. · Cancer · 2004 · 43 citations · Full text

Medicine, Oncology, Surgery +12

Synergistic Induction of Antigen-Specific CTL by Fusions of TLR-Stimulated Dendritic Cells and Heat-Stressed Tumor Cells

Shigeo Koido, Eiichi Hara, Sadamu Homma et al. · The Journal of Immunology · 2007 · 37 citations

Medicine, Immunology, Oncology +17